Inhaled Insulin Afrezza Outsulin

Community Viewpoints: Inhaled Insulin Afrezza (Outsulin)

This blog talks about how the diabetes healthcare community views the inhaled insulin Afrezza. This is the product Mannkind Corporation calls “Outsulin.” The View of “Outsulin” Healthcare providers I know still have not heard of “Outsulin”. Outsulin is the latest marketing campaign from Mannkind Corporation. The campaign explains “Three hours after you…

Afrezza Status BG Chart

Afrezza Status After Eight Months Usage

I have many requests to update my Afrezza status. This article describes only my health status related to using Afrezza. Later, I will write another article to describe community views I collect. Afrezza Status After 8 Months of Use In March of 2016, my Hemoglobin A1C was…

Afrezza+Tresiba+Russia

Day 13 – Afrezza and Tresiba in Russia

I had a hard time picking the subject of this post. It came down to Afrezza and Tresiba in Russia as they were an easy subject for me. Afrezza and Tresiba an Easy Subject Why are Afrezza and Tresiba as easy subject?  It is because life has been simple…

Afrezza – One Diabetics Rocky Road to Better Control

In my last post, I talked about what Afrezza is, my Type 1 diabetes background, and what Afrezza has done for me in a very short time. My trip to using Afrezza was a rocky road, however. I had done plenty of research on inhaled…

Afrezza – a Trip to a Healthier Diabetic

What is Afrezza? In short, it is an inhaled insulin created by MannKind Corporation, based on Technosphere technology, and until recently, marketed and distributed by Sanofi. If you want the short story and some rumors surrounding the breakup of Sanofi and MannKind, The Motley Fool has…